AC
CABA icon

Almitas Capital’s Cabaletta Bio CABA Stock Holding History

Almitas Capital’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Sell
125,900
-211,491
-63% -$696K 0.09% 94
2026
Q1 		$908K Sell
337,391
-50,100
-13% -$139K 0.21% 64
2025
Q4 		$849K Hold
387,491
– – 0.19% 63
2025
Q3 		$907K Buy
387,491
+20,000
+5% +$34.3K 0.21% 45
2025
Q2 		$559K Hold
367,491
– – 0.14% 55
2025
Q1 		$509K Buy
+367,491
New +$783K 0.17% 59

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Almitas Capital's CABA Position: Q2 2026 in Review

Almitas Capital reduced its Cabaletta Bio (CABA) stake by 63% in Q2 2026, selling an estimated $696K and leaving 125,900 shares worth $392K. The position accounts for 0.09% of the portfolio, ranked #94.

Almitas Capital first reported a position in CABA in Q1 2025 and has held it in 6 quarters since. The position peaked at $908K in Q1 2026. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Almitas Capital held 125,900 shares of Cabaletta Bio worth $392K as of Q2 2026.
  • Almitas Capital sold 211,491 Cabaletta Bio shares in Q2 2026, an estimated $696K.
  • Cabaletta Bio made up 0.09% of Almitas Capital's portfolio in Q2 2026, its #94 holding.
  • Almitas Capital first reported a position in Cabaletta Bio in Q1 2025 and has held it in 6 quarters since.
  • Almitas Capital's Cabaletta Bio position peaked at $908K in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Almitas Capital's 13F filing for Q2 2026, filed 17 Aug 2026.